A biomarker test identified tau pathology in Alzheimer's disease before fibrillary tangles developed. Neurofibrillary tangle formation can be prevented by targeting intermediate soluble tau assemblies ...
Soon after the characterization of amyloid-β plaques in the brains of people with Alzheimer’s disease in 1984, scientists determined the composition of the second pathological hallmark spotted by ...
Alzheimer’s disease (AD) is a neurodegenerative disease that causes brain cell death. This progressive disease, which causes a distinct pattern of pathological changes in the brain, is most common ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results